Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer

BackgroundThis study aimed to explore the relationship between creatinine/cystatin C ratio and progression-free survival (PFS) and overall survival (OS) in colorectal cancer (CRC) patients undergoing surgical treatment.MethodsA retrospective analysis was conducted on 975 CRC patients who underwent s...

Full description

Bibliographic Details
Main Authors:	Shunhui Gao, Hailun Xie, Lishuang Wei, Mingxiang Liu, Yanren Liang, Qiwen Wang, Shuangyi Tang, Jialiang Gan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Oncology
Subjects:	creatinine/cystatin C ratio nutrition colorectal cancer progression-free survival overall survival
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1155520/full

Similar Items

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
by: Hailun Xie, et al.
Published: (2023-02-01)

Prognostic significance of preoperative prognostic immune and nutritional index in patients with stage I–III colorectal cancer
by: Hailun Xie, et al.
Published: (2022-12-01)

Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment
by: Hailun Xie, et al.
Published: (2022-11-01)

The value of carcinoembryonic antigen stage in staging, prognosis, and management of colorectal cancer: results from two cohort studies
by: Hailun Xie, et al.
Published: (2023-10-01)

Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective study
by: Hailun Xie, et al.
Published: (2024-06-01)

Serum albumin-carcinoembryonic antigen ratio as an effective clinical tool for predicting recurrence and overall survival in patients with rectal cancer
by: Hailun Xie, et al.
Published: (2025-01-01)

The cancer inflammation prognostic index is a valuable biomarker for predicting the survival of patients with stage I–III colorectal cancer
by: Hailun Xie, et al.
Published: (2023-10-01)

Prognostic value of visceral protein ratios in patients with colon cancer
by: Hailun Xie, et al.
Published: (2024-10-01)

Aminotransferase-to-lymphocyte ratio as a valuable prognostic marker for patients with stage I-III colorectal cancer: a retrospective study
by: Hailun Xie, et al.
Published: (2024-11-01)

The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer
by: Lishuang Wei, et al.
Published: (2024-02-01)

Elevated serum homocysteine levels associated with poor recurrence-free and overall survival in patients with colorectal cancer
by: Hailun Xie, et al.
Published: (2024-05-01)

Prognostic Value of Prognostic Nutritional Index in Patients With Colorectal Cancer Undergoing Surgical Treatment
by: Hailun Xie, et al.
Published: (2022-03-01)

Diagnostic and prognostic value of the Creatinine/Cystatin C ratio for low muscle mass evaluation among US adults
by: Shanshan Shi, et al.
Published: (2022-08-01)

Cystatin C versus Creatinine as Early Stage Diabetic Nephropathy Marker
by: Atteaya Zaman , Amena Rahim , Muhammad Afzal , Abdul Khaliq Naveed
Published: (2018-06-01)

Creatinine-to-cystatin C ratio and frailty in older adults: a longitudinal cohort study
by: Quhong Song, et al.
Published: (2024-09-01)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
by: Yueli Zhu, et al.
Published: (2022-09-01)

A Comparison of Creatinine, Cystatin C, and Creatinine‐Cystatin C Based Equations in HIV/AIDS Patients: A Cross‐Sectional Study
by: Kweku Amoah Ampiah, et al.
Published: (2024-12-01)

Creatinine–cystatin C ratio and mortality in cancer patients: a retrospective cohort study
by: Chan‐Young Jung, et al.
Published: (2022-08-01)

Optimal duration of a first-line palliative chemotherapy in disseminated colorectal cancer – a review of the literature from a developing country perspective
by: Wojciech Rogowski, et al.
Published: (2016-08-01)

Predictive effect of estimated glomerular filtrate rate by creatinine or cystatin C on mortality in patients with coronary artery disease
by: Shiqun Chen, et al.
Published: (2024-12-01)

Diagnostic Value of Serum Creatinine and Cystatin-C-Based Indices and Ishii Score in Cancer-Related Sarcopenia
by: Liming Ding, et al.
Published: (2023-06-01)

Serum creatinine- and cystatin C-based indices are associated with the risk of subsequent sarcopenia: evidence from the China Health and Retirement Longitudinal Study
by: Xin Ning, et al.
Published: (2024-11-01)

Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer
by: Mariko Tsukagoshi, et al.
Published: (2023-09-01)

Relationship between creatinine–cystatin C ratio and all-cause mortality in hospitalized patients with COVID-19: A prospective study in China
by: Dong Wu, et al.
Published: (2024-08-01)

Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States
by: Tianbo Wang, et al.
Published: (2024-07-01)

Estimation of glomerular filtration rate from serum cystatin C and creatinine in patients with thyroid dysfunction
by: Čabarkapa Velibor, et al.
Published: (2012-01-01)

Role of cystatin C in urogenital malignancy
by: Li Ding, et al.
Published: (2022-12-01)

Sex difference in the association between creatinine-to-cystatin C ratio and metabolic syndrome among Chinese adults
by: Jo-Hsuan Chen, et al.
Published: (2024-08-01)

Discordance Between Creatinine-Based and Cystatin C–Based Estimated GFR: Interpretation According to Performance Compared to Measured GFRPlain-Language Summary
by: Yeli Wang, et al.
Published: (2023-10-01)

The Inter-Trimester Variation and Prognostic Value of Creatinine, Cystatin C and Uric Acid in Preeclamptic Patients: A Retrospective Study
by: Junpeng Jing, et al.
Published: (2023-02-01)

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery
by: Yan Liu, et al.
Published: (2024-04-01)

Corrigendum: Sex difference in the association between creatinine-to-cystatin C ratio and metabolic syndrome among Chinese adults
by: Jo-Hsuan Chen, et al.
Published: (2024-10-01)

Prognostic values of blood urea nitrogen/creatinine and cystatin C in patients with radical nephrectomy for renal cell carcinoma
by: Wang SiCheng, et al.
Published: (2024-01-01)

Estimating eGFR using Serum Cystatin C alone and in combination with Serum Creatinine: A Prospective study in individuals with CKD in north Telangana
by: B Venugopal1 , S Sangeeta2
Published: (2018-08-01)

Grading carcinoembryonic antigen levels can enhance the effectiveness of prognostic stratification in patients with colorectal cancer: a single-centre retrospective study
by: Hailun Xie, et al.
Published: (2024-10-01)

Predictive value of creatinine-cystatin C ratio for mortality and technique failure in anuric peritoneal dialysis patients
by: Zhihong Zhang, et al.
Published: (2025-12-01)

Differential Bias for Creatinine- and Cystatin C- Derived Estimated Glomerular Filtration Rate in Critical COVID-19
by: Anders O. Larsson, et al.
Published: (2022-10-01)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
by: Jung Nam An, et al.
Published: (2022-09-01)

Comparison of Creatinine and Cystatin C to Estimate Renal Function in Geriatric and Frail Patients
by: Erik Dahlén, et al.
Published: (2022-06-01)